Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Argus Health
Fish and Richardson
Harvard Business School
Novartis
Queensland Health
Medtronic
Express Scripts
Healthtrust
Farmers Insurance

Generated: October 24, 2017

DrugPatentWatch Database Preview

TENORMIN Drug Profile

« Back to Dashboard

What is the patent landscape for Tenormin, and when can generic versions of Tenormin launch?

Tenormin is a drug marketed by Alvogen Malta and Astrazeneca and is included in two NDAs.

The generic ingredient in TENORMIN is atenolol. There are thirty-three drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the atenolol profile page.

Summary for Tradename: TENORMIN

US Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list89
Clinical Trials: see list5
Patent Applications: see list6,696
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TENORMIN at DailyMed

Pharmacology for Tradename: TENORMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990ABRXYesNo► Subscribe► Subscribe► Subscribe
Astrazeneca
TENORMIN
atenolol
INJECTABLE;INJECTION019058-001Sep 13, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982ABRXYesNo► Subscribe► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TENORMIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-004Apr 9, 1990► Subscribe► Subscribe
Alvogen Malta
TENORMIN
atenolol
TABLET;ORAL018240-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Medtronic
UBS
Deloitte
Chinese Patent Office
Boehringer Ingelheim
QuintilesIMS
Farmers Insurance
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot